Chemotherapy and Low Dose Radiotherapy for Childhood Hodgkin's Disease
Author Information
Author(s): Viani Gustavo A, Castilho Marcus S, Novaes Paulo E, Antonelli Celia G, Ferrigno Robson, Pellizzon Cassio A, Fogaroli Ricardo C, Conte Maria A, Salvajoli Joao V
Primary Institution: Department of Radiation Oncology Hospital do Câncer, Sao Paulo, Brazil
Hypothesis
What are the treatment results and prognostic factors for childhood patients with Hodgkin's disease treated with chemotherapy followed by low dose radiotherapy?
Conclusion
The study shows that low dose radiotherapy consolidation is important for improving survival rates in childhood Hodgkin's disease.
Supporting Evidence
- The overall survival (OS) and event-free survival (EFS) rates at 10 years were 89% and 87%, respectively.
- Survival rates varied by clinical stage, with stage I at 94.7% and stage IV at 71%.
- Patients who received radiotherapy had a higher OS of 91.3% compared to 72.6% for those who did not.
Takeaway
Kids with Hodgkin's disease can get better with a mix of medicine and a little bit of radiation, which helps them live longer and healthier.
Methodology
This was a retrospective analysis of 166 patients under 18 years old treated from January 1985 to December 2003.
Potential Biases
Potential biases include selection bias due to the retrospective nature of the study.
Limitations
The study is retrospective and may not account for all variables affecting outcomes.
Participant Demographics
Median age was 10 years, with a male to female ratio of 2.3:1; 83.1% were white.
Statistical Information
P-Value
p = 0.003
Confidence Interval
IC95%-1.3 – 4.3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website